COVID-19 therapeutics: how to sow confusion and break public trust during international public health emergencies
Jerome Amir Singh, Rafaella Ravinetto
Abstract
, those tasked with the stewardship of public health at a global, regional, and local level-policymakers, politicians, scientists, drug regulators, health officials, professional associations, journal editors, publishers, and clinicians-have displayed rushed decisions and lapses in judgment in their handling of chloroquine and hydroxychloroquine as potential COVID-19 therapeutics and prophylactics. These lapses merit noting as they hold lessons for how the guardians of medicines regulation and public health can inadvertently sow confusion and damage public trust.
Topics & Concepts
Public healthConfusionCoronavirus disease 2019 (COVID-19)Stewardship (theology)PharmacyPandemicMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPublic relationsPublic trustPolitical scienceFamily medicineNursingPsychologyLawVirologyPathologyInfectious disease (medical specialty)OutbreakPsychoanalysisPoliticsDiseaseCOVID-19 Clinical Research StudiesAntibiotic Use and ResistanceVitamin C and Antioxidants Research